| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2025 | Feb 4, 2025 | Atea Pharmaceuticals, Inc. | EVP, Chief Accounting Officer | Sell | 26.3 | -4,062 | -7.50% | ✗ | $36.9K |
| Jan 31, 2024 | Feb 2, 2024 | Atea Pharmaceuticals, Inc. | EVP, Chief Accounting Officer | Sell | 13.8 | -12,477 | -37.43% | ✓ | $47.9K |